IVD Raw Material Market Report 2025 (Global Edition)

Global IVD Raw Material Market Report 2025 Market Size Split by Product Type (Antibody, Antigens, Proteins, Enzymes, Biological Buffers, Substrates, Others), by Technology (Molecular Diagnostics, Clin...

IVD Raw Material Market Report Description

We have various report editions of IVD Raw Material Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

IVD Raw Material Market Insights Video

Competitive Landscape of the IVD Raw Material Market

The market for IVD raw materials is highly competitive, with major companies emphasizing scalability, quality, and innovation. Prominent firms with global reach and vast product portfolios include Agilent Technologies, F. Hoffmann-La Roche, Merck KGaA, and Thermo Fisher Scientific. Up-and-coming firms concentrate on specialized raw materials such as recombinant proteins and personalized antibodies. Companies frequently enter into strategic alliances, mergers, and acquisitions in an effort to increase their capabilities and market share.

In August 2022, Biosynth, a vital materials supplier to the life science industry, announced the acquisition of EUCODIS Bioscience. This company specializes in enzyme engineering and development for the pharmaceutical, biotech, and application markets. The two firms have collaborated on innovative initiatives related to enzyme development for some years. As part of its extensive range of research products, Biosynth already stocks the enzymes from EUCODIS' catalog. (Source:https://www.biosynth.com/news/biosynth-carbosynth-to-offer-enzyme-development-following-acquisition-of-eucodis-bioscience) In June 2022, Medix Biochemica, based in Espoo, Finland, acquired 100% of Bioresource Technology's shares to expand its base matrix capabilities and fortify its local position in the US market. Medix will provide its clients with a wide range of raw materials for their in vitro diagnostics (IVD) quality control solutions. (Source:https://articles.medixbiochemica.com/bioresource-technology-joins-medix-biochemica-group) In March 2022, Medix Biochemica unveiled a refreshed brand to showcase its continued dedication to the in vitro diagnostics (IVD) market and the enhancements made to its portfolio through recent acquisitions. Its goal is to become the premier source of IVD raw materials, and it expects to achieve this goal through rapid expansion. (Source: https://articles.medixbiochemica.com/medix-biochemica-launches-refreshed-and-expanding-brand)

Top Companies Market Share in IVD Raw Material Industry: (In no particular order of Rank)

• Aalto Bio Reagents
• Merck KgaA
• F. Hoffmann-La Roche
• Fapon Biotech
• Fujirebio
• Thermo Fisher Scientific
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the IVD Raw Material Market

Which Region Dominates the IVD Raw Material Market in 2024?

According to Cognitive Market Research, North America currently dominates the IVD Raw Material market, and the region is expected to have significant growth during the projected period. Due to its highly developed healthcare system, high rate of chronic illness, and emphasis on individualized therapy, North America is a major growth engine for the IVD raw material market. The area is a leader in the development of point-of-care testing, PCR, NGS, and other molecular diagnostic technologies. There is a greater need for high-quality raw materials such as antibodies, enzymes, and antigens due to the existence of significant IVD enterprises and research institutions, especially in the United States. North America is positioned as a key growth hub for IVD raw materials because of favorable regulatory regulations and large investments in healthcare R&D, which foster market expansion.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The IVD raw materials market in China has a significant influence on the dynamics of the Asia-Pacific IVD raw materials market. China is prioritizing the advancement of its indigenous healthcare sector in an effort to lessen its reliance on imports. This will encourage domestic IVD raw material production. Furthermore, the Chinese government is working hard to upgrade the nation's healthcare system. Additionally, the market for IVD raw materials in India is growing because of the country's large population and high unmet medical demand. This offers the IVD market, and thus IVD raw material suppliers, enormous opportunities. Furthermore, chronic diseases like cancer and diabetes are becoming more common in India.

The current report Scope analyzes IVD Raw Material Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America IVD Raw Material

According to Cognitive Market Research, the global IVD Raw Material market size was estimated at USD 15241.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 6096.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.4% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the IVD Raw Material market with a market size of USD 4810.12 million in 2024 and is projected to grow at a CAGR of 12.2% during the forecast period. The United States is driving the demand for cutting-edge IVD raw materials, leading in diagnostic technology innovation.
• The Canada IVD Raw Material market had a market share of USD 731.58 million in 2024 and is projected to grow at a CAGR of 13.2% during the forecast period. In Canada, the development of innovative diagnostic techniques is facilitated by increased financing for healthcare and research.
• The Mexico IVD Raw Material market is projected to witness growth at a CAGR of 12.9% during the forecast period, with a market size of USD 554.78 million in 2024.

Europe IVD Raw Material

According to Cognitive Market Research, the global IVD Raw Material market size was estimated at USD 15241.2 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 4572.36 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.7% from 2024 to 2031.

• The United Kingdom IVD Raw Material market had a market share of USD 768.16 million in 2024 and is projected to grow at a CAGR of 13.5% during the forecast period. Specialized diagnostic tests and raw materials are necessary because of the UK's emphasis on customized therapies.
• The France IVD Raw Material market is projected to witness growth at a CAGR of 11.9% during the forecast period, with a market size of USD 420.66 million in 2024.
• According to Cognitive Market Research, the German IVD Raw Material market size was valued at USD 905.33 million in 2024 and is projected to grow at a CAGR of 12.9% during the forecast period. The robust biotech sector in Germany drives up demand for premium diagnostic raw ingredients.
• The Italy IVD Raw Material market is projected to witness growth at a CAGR of 12.1% during the forecast period, with a market size of USD 393.22 million in 2024.
• The Russia IVD Raw Material market is projected to witness growth at a CAGR of 11.7% during the forecast period, with a market size of USD 708.72 million in 2024.
• The Spain IVD Raw Material market is projected to witness growth at a CAGR of 11.8% during the forecast period with a market size of USD 374.93 million in 2024
• The Luxembourg IVD Raw Material market is projected to witness growth at a CAGR of 12.8% during the forecast period, with a market size of USD 141.74 million in 2024.
• The Portugal IVD Raw Material market is projected to witness growth at a CAGR of 12.5% during the forecast period, with a market size of USD 96.02 million in 2024.
• The Greece IVD Raw Material market is projected to witness growth at a CAGR of 13.0% during the forecast period, with a market size of USD 54.87 million in 2024.
• The Rest of Europe's IVD Raw Material market is projected to witness growth at a CAGR of 11.4% during the forecast period, with a market size of USD 708.72 million in 2024.

Asia Pacific IVD Raw Material

According to Cognitive Market Research, the global IVD Raw Material market size was estimated at USD 15241.2 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 3505.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 16.2% from 2024 to 2031.

• According to Cognitive Market Research, the China IVD Raw Material market size was valued at USD 1577.46 million in 2024 and is projected to grow at a CAGR of 15.7% during the forecast period. IVD Raw Material sales surged in China due to increased access to healthcare due to urbanization driving up demand for diagnostic tools and testing.
• The Japan IVD Raw Material market is projected to witness growth at a CAGR of 14.7% during the forecast period, with a market size of USD 483.76 million in 2024.
• The India IVD Raw Material market had a market share of USD 420.66 million in 2024 and is projected to grow at a CAGR of 18.0% during the forecast period. In India, the need for raw materials and diagnostic services is raised by an aging and increasing population.
• The South Korean IVD Raw Material market is projected to witness growth at a CAGR of 15.3% during the forecast period, with a market size of USD 350.55 million in 2024.
• The Australian IVD Raw Material market is projected to witness growth at a CAGR of 15.9% during the forecast period, with a market size of USD 182.28 million in 2024.
• The South East Asia IVD Raw Material market is projected to witness growth at a CAGR of 17.2% during the forecast period, with a market size of USD 241.88 million in 2024.
• The Rest of Asia Pacific IVD Raw Material market is projected to witness growth at a CAGR of 16.0% during the forecast period, with a market size of USD 248.89 million in 2024.

South America IVD Raw Material

According to Cognitive Market Research, the global IVD Raw Material market size was estimated at USD 15241.2 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 762.06 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.6% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil IVD Raw Material market size was valued at USD 326.16 million in 2024 and is projected to grow at a CAGR of 14.2% during the forecast period. IVD Raw Material flourished in Brazil because the high incidence of infectious diseases increases the need for appropriate diagnostic tools.
• Argentina's IVD Raw Material market had a market share of USD 128.03 million in 2024 and is projected to grow at a CAGR of 14.5% during the forecast period. In Argentina, the biopharmaceutical industry's growth is driving up demand for IVD raw materials.
• Colombia IVD Raw Material market is projected to witness growth at a CAGR of 13.4% during the forecast period, with a market size of USD 67.82 million in 2024.
• Peru IVD Raw Material market is projected to witness growth at a CAGR of 13.8% during the forecast period, with a market size of USD 62.49 million in 2024.
• Chile's IVD Raw Material market is projected to witness growth at a CAGR of 13.9% during the forecast period, with a market size of USD 54.87 million in 2024.
• The Rest of Latin America's IVD Raw Material market is projected to witness growth at a CAGR of 12.7% during the forecast period, with a market size of USD 122.69 million in 2024.

Middle East IVD Raw Material

According to Cognitive Market Research, the global IVD Raw Material market size was estimated at USD 15241.2 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 304.82 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.9% from 2024 to 2031..

• The GCC Countries IVD Raw Material market is projected to witness growth at a CAGR of 14.7% during the forecast period, with a market size of USD 130.46 million in 2024. IVD Raw Material sales flourish in GCC countries due to the need for remote diagnostic testing capabilities fueled by the growth of telehealth solutions.
• The Egypt IVD Raw Material market is projected to witness growth at a CAGR of 14.2% during the forecast period, with a market size of USD 32.01 million in 2024.
• The South Africa IVD Raw Material market is projected to witness growth at a CAGR of 14.9% during the forecast period, with a market size of USD 48.16 million in 2024. Diagnostic testing is more in demand when diseases like HIV/AIDS and TB are prevalent in South Africa.
• The Turkey IVD Raw Material market is projected to witness growth at a CAGR of 13.4% during the forecast period, with a market size of USD 26.21 million in 2024.
• The Nigeria IVD Raw Material market is projected to witness growth at a CAGR of 13.0% during the forecast period, with a market size of USD 32.01 million in 2024.
• The Rest of the MEA IVD Raw Material market is projected to witness growth at a CAGR of 12.9% during the forecast period, with a market size of USD 35.97 million in 2024.

IVD Raw Material Market Analysis

IVD Raw Material Market Product Type Segment Analysis

According to Cognitive Market Research, antibodies are likely to dominate the IVD Raw Material Market over the forecast period. Because of their crucial role in providing highly specific analyte detection and targeting in diagnostic assays, they are necessary for precise disease diagnosis and patient care. Antibodies are crucial elements of many diagnostic assays, helping to identify and detect a wide variety of illnesses. In diagnostics, two primary categories of antibodies are utilized: monoclonal and polyclonal. These antibodies are used as building blocks for the creation of diagnostic assays, including immunohistochemistry (IHC), lateral flow assays, and enzyme-linked immunosorbent assays (ELISAs).

The antigens are the fastest-growing segment in the IVD Raw Material Market. Antigens are essential components of the IVD raw material market; they are mainly utilized in immunoassays, such as serological assays, lateral flow tests, and ELISA. By assisting in the identification of particular antibodies in a patient's sample, they facilitate the diagnosis of infectious disorders such as hepatitis, HIV, and COVID-19. Antigens are also employed in the diagnosis of cancer and blood typing. These resources support early disease diagnosis and surveillance by enabling the creation of highly sensitive and specific diagnostic tests. Their contribution is crucial to the development of dependable, accurate IVD tests for use in a range of healthcare environments.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of IVD Raw Material Industry. Request a Free Sample PDF!

IVD Raw Material Market Technology Segment Analysis

According to Cognitive Market Research, the immunochemistry segment holds the largest share of the market. Because of its adaptability in finding a variety of analytes with high specificity and sensitivity, it positions it as a key technology in diagnostic tests for a range of illnesses and ailments. Antigens, antibodies, and other compounds are found and measured in biological materials using immunochemistry. This field makes use of the unique ways that antigens and antibodies attach to facilitate precise disease monitoring and diagnosis. The diagnosis of cancer, autoimmune diseases, viral diseases, and hormone abnormalities is greatly aided by immunochemistry. Among other uses, it is employed in allergy testing and therapeutic medication monitoring. Common methods used in immunochemistry are immunoassays, such as chemiluminescent immunoassays (CLIA) and enzyme-linked immunosorbent assays (ELISA).

In the IVD Raw Material Market, the category of molecular diagnostics has been growing quickly. The IVD raw material market is seeing a sharp rise in demand for molecular diagnostics technology due to the growing requirement for accurate and timely disease diagnosis. High-quality raw materials, including nucleotides, enzymes, and primers, are needed for technologies like PCR, next-generation sequencing (NGS), and CRISPR-based tests. This need is further increased by the growing emphasis on customized medicine as well as the increased incidence of infectious diseases and genetic abnormalities. As a result of their ability to yield better treatment outcomes through insightful patient management, molecular diagnostics are becoming increasingly important in contemporary healthcare and are propelling substantial expansion in the raw material market.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

IVD Raw Material End-User Segment Analysis

IVD Raw Material Market End-User Segment Analysis

According to Cognitive Market Research, the pharma, biotech & medtech companies segment holds the largest market share. Pharmaceutical, biotech, and medtech companies are important end users in the IVD raw material market because they employ raw materials to manufacture medical devices and diagnostic tests. Premium materials, including enzymes, antibodies, and nucleotides, are necessary for these companies to develop tests for disease diagnosis, monitoring, and customized therapy. Rapid diagnostics and point-of-care testing advancements are driving demand. These sectors work together to produce new products and technologies that improve the effectiveness of diagnosis and treatment methods while also driving the market.

Diagnostic laboratories are anticipated to be the fastest-growing segment in the IVD Raw Material market. Diagnostic labs are a crucial end-user market segment for IVD raw materials, and they are used to run a range of tests for patient monitoring and illness identification. The development of precise tests for infectious diseases, chronic ailments, and genetic testing in these labs depends on high-quality supplies like antibodies, enzymes, and nucleotides. Dependability on raw materials is becoming more and more important as the requirement for accurate and timely diagnostics grows along with the number of ailments. Demand for novel and standardized raw materials keeps rising as diagnostic labs get more sophisticated, which drives market expansion.

• Pharma
• Biotech & MedTech Companies
• Diagnostic Laboratories
• Others

Author's Detail

Manoj Phagare

Senior Research Analyst at Cognitive Market Research

LinkedIn

Profile

• Worked on several market, industry & business research projects, on various models such as Syndicated, Custom, Subscriptions and Consults
• Proficient in secondary research and familiar with all paid research databases
• Proficient in primary research and handling client queries through mails and calls
• Expertise in statistical techniques used in data forecasting, possess strong grip on all aspects of market engineering & data analysis
• Expertise in checking feasibility of projects based on Request for Proposal (RFPs) of clients
• Acquainted with entire process of report writing- Title Analysis, TOC Building, Search Engine Optimization, TOC Freezing, Writing Reports, Market Engineering, Scheduling Primaries, Directory of Key Industry Participants (DKIP), Drafting “Press Articles/Summary/Report Description/Analyst Briefing” used for making marketing collaterals 
• Gained team-work skills in coordinating with the sales teams for business development and meeting needs of a variety of clients hand-in-hand with promoting sales.

Author's Conclusion